Studies Show Avastin Doesn't Increase Breast Cancer Survival Rate

By: CBS News Email
By: CBS News Email

47-year old Erika Rotheim took the popular cancer drug Avastin to treat her breast cancer. After 2 months she was in complete remission.

The drug did help Erika, but studies have shown it doesn't increase survival rates for most breast cancer patients and can have serious side effects. So the FDA now says Avastin should no longer be used for the treatment of advanced breast cancer .

Avastin is approved for other uses like colon and lung cancers so doctors can still prescribe it . But, for breast cancer, insurance companies may not pay .

The makers of Avastin say despite the decision, they will begin research to see if it can still be used in certain breast cancer cases

WCTV 1801 Halstead Blvd. Tallahassee, FL 32309
Copyright © 2002-2016 - Designed by Gray Digital Media - Powered by Clickability 134174808 -
Gray Television, Inc.